• Tue. Jun 6th, 2023

Boston Scientific found guilty of infringing on drug-eluting stent patent, fined $42M

By

Feb 3, 2023
Half a decade after it began, an intellectual property case between Boston Scientific and TissueGen has finally reached a verdict. | Half a decade after it began, an intellectual property case between Boston Scientific and TissueGen has finally reached a verdict.

Read More